2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4393):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-Z4535
    Nintedanib impurity 6
    		99.90%
    Nintedanib impurity 6 is an impurity of Nintedanib (HY-50904).
    Nintedanib impurity 6
  • HY-W037792
    tert-Butyl (R)-3-(4-chlorophenyl)piperazine-1-carboxylate
    tert-Butyl (R)-3-(4-chlorophenyl)piperazine-1-carboxylate is a drug intermediate for synthesis of various active compounds.
    tert-Butyl (R)-3-(4-chlorophenyl)piperazine-1-carboxylate
  • HY-42520
    (S)-4-Benzyl-3-(5-bromopentanoyl)oxazolidin-2-one
    		99.85%
    (S)-4-Benzyl-3-(5-bromopentanoyl)oxazolidin-2-one is a drug intermediate for synthesis of various active compounds.
    (S)-4-Benzyl-3-(5-bromopentanoyl)oxazolidin-2-one
  • HY-W087424
    Theophylline impurity 9
    		≥98.0%
    Theophylline impurity 9 is an impurity of Theophylline (HY-B0809).
    Theophylline impurity 9
  • HY-Z0017
    Indobufen impurity 4
    		98.88%
    Indobufen impurity 4 is an impurity of Indobufen (HY-18763).
    Indobufen impurity 4
  • HY-W010615
    2-Methylthiophene
    		99.94%
    4-Methylthiophene is an intermediate used in the synthesis of the aromatic sulfur compounds.
    2-Methylthiophene
  • HY-114327
    D-Ribose 1,5-diphosphate
    D-Ribose 1,5-diphosphate (R15P) is a metabolic intermediate and enzyme substrate. Purified Tk-E2b2 converts D-Ribose 1,5-diphosphate into Ribulose-1,5-bisphosphate, with a specific activity of 32.3 μmol min-1 mg-1[1].
    D-Ribose 1,5-diphosphate
  • HY-76819
    Benzyl (3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ylcarbamate
    		98.47%
    Benzyl (3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ylcarbamate is a drug intermediate for synthesis of various active compounds.
    Benzyl (3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ylcarbamate
  • HY-W102375
    4-Acetoxycinnamic acid
    		98.37%
    4-Acetoxycinnamic acid is an acetate ester obtained by the formal condensation of the hydroxy group of trans-4-coumaric acid with acetic acid. 4-Acetoxycinnamic acid is a member of cinnamic acids and a member of phenyl acetates. 4-Acetoxycinnamic acid derives from a trans-4-coumaric acid.
    4-Acetoxycinnamic acid
  • HY-135321
    Levetiracetam impurity 1
    		98.0%
    Levetiracetam impurity 1 is an impurity of Levetiracetam (HY-B0106).
    Levetiracetam impurity 1
  • HY-20559
    4-Chloro-3-nitrobenzoic acid
    		99.39%
    4-Chloro-3-nitrobenzoic acid is a benzoic acid derivative and an important intermediate for the synthesis of anticancer agents. 4-Chloro-3-nitrobenzoic acid shows low cytotoxicity against HepG2, A549 and HeLa cancer cells in vitro (>10,000 μM). 4-Chloro-3-nitrobenzoic acid can block thymidine uptake and inhibit lymphocyte growth. 4-Chloro-3-nitrobenzoic acid serves as a ligand for Cu (II) complexes and is used in the preparation of 10H-pyrazino[2,3-b][1,4]benzothiazine derivatives.
    4-Chloro-3-nitrobenzoic acid
  • HY-W018629
    Antibacterial agent 265
    		99.59%
    Antibacterial agent 265 (Compound 2) is an antibacterial agent. Antibacterial agent 265 shows antibacterial activity against Staphylococcus Aureus, Micrococcus Luteus, Bacillus subtilis, gram-negative Escherichia coli, Pseudomonas aeruginosa and Flavobacterium devorans.
    Antibacterial agent 265
  • HY-78394
    tert-Butyl chlorosulfonylcarbamate compound with 1,4-diazabicyclo[2.2.2]octane (1:2)
    tert-Butyl chlorosulfonylcarbamate compound with 1,4-diazabicyclo[2.2.2]octane (1:2) is a drug intermediate for synthesis of various active compounds.
    tert-Butyl chlorosulfonylcarbamate compound with 1,4-diazabicyclo[2.2.2]octane (1:2)
  • HY-W075796
    Copper(I) thiocyanate
    		99.1%
    Copper (I) thiocyanate is a monovalent copper pseudohalide that exists in two crystalline forms, α and β, both containing bridging thiocyanate groups. Copper (I) thiocyanate can form coordination complexes with ligands such as triphenylphosphine and pyridine.
    Copper(I) thiocyanate
  • HY-W035272
    3-Oxo-2,3-dihydro-1H-indazole-5-carboxylic acid
    		99.00%
    3-Oxo-2,3-dihydro-1H-indazole-5-carboxylic acid is a drug intermediate for synthesis of various active compounds.
    3-Oxo-2,3-dihydro-1H-indazole-5-carboxylic acid
  • HY-43132
    21-Chloro-3,6,9,12,15-pentaoxahenicosan-1-ol
    21-Chloro-3,6,9,12,15-pentaoxahenicosan-1-ol is a drug intermediate for synthesis of various active compounds.
    21-Chloro-3,6,9,12,15-pentaoxahenicosan-1-ol
  • HY-23946
    5-Fluoro-2-methylpyridin-3-amine
    		99.64%
    5-Fluoro-2-methylpyridin-3-amine is a drug intermediate for synthesis of various active compounds.
    5-Fluoro-2-methylpyridin-3-amine
  • HY-W065670
    3-Methoxyisoquinoline-1-carboxylic acid
    		99.61%
    3-Methoxyisoquinoline-1-carboxylic acid is a drug intermediate for synthesis of various active compounds.
    3-Methoxyisoquinoline-1-carboxylic acid
  • HY-78397
    2-((1s,4s)-4-Phenylcyclohexyl)acetic acid
    		99.74%
    2-((1s,4s)-4-Phenylcyclohexyl)acetic acid is a drug intermediate for synthesis of various active compounds.
    2-((1s,4s)-4-Phenylcyclohexyl)acetic acid
  • HY-W004415
    Umeclidinium bromide impurity 8
    Umeclidinium bromide impurity 8 is an impurity of Umeclidinium Bromide (HY-12100).
    Umeclidinium bromide impurity 8